107757-06-2 Usage
Uses
Used in Pharmaceutical Industry:
3-Methyl-5-nitrobenzaldehyde is used as a synthetic intermediate for the production of various pharmaceuticals. Its role in the synthesis of complex organic molecules makes it a valuable component in the development of new drugs.
Used in Dye Industry:
In the dye industry, 3-Methyl-5-nitrobenzaldehyde is utilized as a precursor in the synthesis of different types of dyes, contributing to the coloration of textiles and other materials.
Used in Pesticide and Insecticide Production:
3-Methyl-5-nitrobenzaldehyde is used as a starting material in the formulation of pesticides and insecticides, highlighting its importance in agricultural chemistry for pest control.
Used in Medicinal Chemistry Research:
3-Methyl-5-nitrobenzaldehyde is employed as a subject of study in medicinal chemistry due to its potential antimicrobial and anticancer properties, indicating its use in the development of new therapeutic agents.
Used as a Reagent in Organic Chemistry:
3-Methyl-5-nitrobenzaldehyde serves as a reagent in various organic chemistry reactions, facilitating the synthesis of a wide array of organic compounds for research and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 107757-06-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,7,5 and 7 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 107757-06:
(8*1)+(7*0)+(6*7)+(5*7)+(4*5)+(3*7)+(2*0)+(1*6)=132
132 % 10 = 2
So 107757-06-2 is a valid CAS Registry Number.
107757-06-2Relevant academic research and scientific papers
ADRENERGIC AMIDINES
-
, (2008/06/13)
Disclosed herein are adrenergic compounds represented by the formula STR1 wherein m is 0, 1 or 2; R 1, R 2, R 3 and R. sub.7 are taken from the group consisting of hydrogen, hydroxy, loweralkyl, loweralkoxy, halo, amino, acetamido or NHSO 2 R wherein R is taken from the group consisting of hydrogen or loweralkyl, provided that R 1, R 2, R. sub.3 and R 7 cannot simultaneously be hydrogen or halo, and provided that when one of R 1, R 2, R 3 and R 7 is halo, the others cannot simultaneously be hydrogen and when two of R 1, R 2, R 3 and R 7 are halo, the other two cannot simultaneously be hydrogen and provided that R 1 and R 7 cannot simultaneously be methoxy each when R. sub.2 and R 3 are hydrogen; R. sub.1 and R 2 or R 2 and R 3 or R 3 and R. sub.7 taken together can form a methylenedioxy or ethylenedioxy bridge; or R 1 and R 2 or R 2 and R 3 or R 3 and R. sub.7 taken together with the aromatic ring can form a benzimidazole or indole bridge; and R. sub.4 and R 5 are hydrogen or taken together form a closed ring of the formula STR2 wherein n is 1 or 2, and the combined solid and dashed line represents a single or double bond when n is 1, and R 6 is taken from the group consisting of hydrogen or loweralkyl, and the pharmaceutically acceptable salts thereof.
